Brian Matusz back on track after having wart removed

3 Comments

Brittany Ghiroli of MLB.com reports that Brian Matusz threw a bullpen session today, just one day after from having a wart removed from his left middle finger.

“It feels fine. It doesn’t feel irritated at all. It feels normal. Like I said before, it never affected me on the mound. It didn’t affect any of my pitches. We just wanted to fix it before it became a problem. It felt good. I threw all of my pitches and it was fine. I didn’t feel like I had to hold back at all, so I’m on schedule.”

While it was originally assumed that Matusz would need a few days to recover, Ghiroli writes that it’s increasingly likely that the young southpaw will be available to make his next scheduled start on Tuesday.

Matusz, 24, went 10-12 with a 4.30 ERA over 32 starts last season, including a 2.11 ERA and 52/16 K/BB ratio after August 1. The American League East isn’t an easy place to have success, especially for an extreme fly-ball pitcher, but Matusz is the closest thing the Orioles have to an ace right now.

Yankees sign Adam Lind to a minor league deal. Again.

Getty Images
Leave a comment

The Yankees signed Adam Lind to a minor league deal this past offseason. Then they released him during spring training. Now they have signed him to another minor league deal. He’ll report to extended spring training where he’ll now try not to get extended released.

Lind is a platoon guy with little defensive value, but he hit .303/.362/.513 with 14 home runs and 59 RBI in 301 plate appearances for the Nationals last season, serving as a pinch-hitter and backup first baseman and outfielder. The injury to Greg Bird and the impending suspension of Tyler Austin — he’s currently on appeal — will likely give him at least some opportunity to show that he’s still a big leaguer.

Which, yeah, he probably still is. Or at least would be if teams didn’t have 13 and 14-man pitching staffs and actually had room for a couple of bench position players. Such is not the current game of baseball, however.